The Department of Pathology and Laboratory Medicine at Memorial Sloan Kettering Cancer Center offers a one-year fellowship training program in bone and soft tissue pathology. The fellowship begins on July 1st and ends on June 30th the following year. All fellows should have completed residency training in anatomic pathology and be certified (or eligible for certification) by the American Board of Pathology.
During the sub-specialty fellowship year, the fellow will have the opportunity to study our large volume of quality in-house and submitted material, departmental consultation case material, as well as recommended reading of literature to achieve adequate competence in the pathologic diagnosis, staging, and prognostication of a wide variety of bone and soft tissue tumors. In addition, the fellow will have the opportunity to perform clinico-pathologic and molecular correlations. The fellow will serve as a consultant to the oncologic pathology fellows in the orientation, gross dissection and morphologic evaluation of bone and soft tissue specimens. Fellows are integrated into a multidisciplinary team of experts in bone and soft tissue oncology, surgery, radiology and radiation oncology. We provide ample opportunities to engage in independent and collaborative clinicopathologic and translational research. During the process of attendance of daily sign out, the fellow would have had the opportunity to review approximately 3000 cases during the course of the fellowship year. Fellows have access to intradepartmental and institutional didactics across the breadth of the disciplines of pathology and oncology.
Goals and Objectives
The goals of the Bone and Soft Tissue Fellowship are:
- To enable the fellow to gain sufficient experience in diagnosis of bone and soft tissue tumors.
- To spend adequate time in research to study clinicopathological correlations and molecular alterations in rare tumors.
- To contribute to academic activity with scholarly publications in the field of bone and soft tissue pathology.
The Objectives of the Bone and Soft Tissue Fellowship are:
- The fellow will attend daily sign out sessions.
- The fellow will work with rotating surgical pathology fellows and follow through large resection specimens to understand gross pathology, radiology and microscopic correlations.
- The fellow will help prepare for conferences and disease management team presentations.
- The fellow will spend part of the time on research projects with a goal towards completion and scholarly publications within the year.
Applicants should have demonstrated a sustained interest in bone and soft tissue disease and evidence of strong oral and written communication skills.
Download a Bone and Soft Tissue Pathology Fellowship Program brochure.
NRMP Match
The MSKCC Bone and Soft tissue pathology fellowship will be participating in an NRMP administered match process starting in the 2026-2027 academic year. Applications are still accepted online via our website. Additional details regarding the match process will be provided soon.
Availability
2026
Deadline
November 30
Length of Program
One year
Number of Positions
One
How to Apply
We are proudly participating in the Unified Approach and Common Timeline for surgical pathology and surgical pathology subspecialty fellowship recruitment. For more information on the Surgical Pathology Unified Approach, visit: https://apc.memberclicks.net/surgpath-recruitment-page. This page has the Unified Approach Guidelines for 2025-2026, Code of Conduct, FAQs, and tips for applicants.
Important Dates:
Application deadline: July 21
August 14, 2023: start of interviews for 2025-2026 positions (All interviews will be virtual)
October 2, 2023: First day offers will be made for 2025-2026 positions
Stipend and Maintenance
The stipend is commensurate with the year of the applicant’s postgraduate training. Nearby housing is available with rents that are comparable to NYC market rates; professional liability insurance and health coverage are provided free of charge.
Facilities
Memorial Hospital for Cancer and Allied Diseases is a 425-bed hospital devoted to the care of patients with neoplastic diseases. The hospital is part of the Memorial Sloan Kettering Cancer Center, which also includes Sloan Kettering Institute for Cancer Research. There is an affiliation and close interaction between the clinical and research units of the Center and the Weill Medical College of Cornell University, as well as with Rockefeller University.